Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 6Sarcoma 5Liposarcoma 4Leiomyosarcoma 3Neoplasms 2Fallopian Tube Neoplasms 2Sarcoma, Ewing 1Recurrent High Grade Meningioma 1Recurrence 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm Metastasis 1Liposarcoma, Myxoid 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1

Interventions

Ifosfamide 6X-Rays 5Phantoms, Imaging 5Magnetic Resonance Spectroscopy 5Filgrastim 5Etoposide 5Doxorubicin 5Cyclophosphamide 5Vincristine 4Temozolomide 4Specimen Handling 4Radiotherapy 4Nuclear Medicine Department, Hospital 4Melphalan 4Thiotepa 3Irinotecan 3Biopsy 3Bevacizumab 3ulixertinib 2trioctyl phosphine oxide 2tipifarnib 2temsirolimus 2tazemetostat 2selpercatinib 2palbociclib 2olaparib 2larotrectinib 2ivosidenib 2erdafitinib 2cixutumumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Neuroectodermal Tumors, Primitive, Peripheral × Trabectedin × Clear all
NCT00070109 2018-09-14

Trabectedin in Treating Young Patients With Recurrent or Refractory Soft Tissue Sarcoma or Ewing's Family of Tumors

Children's Oncology Group

Phase 2 Completed
50 enrolled 18 charts
Sarcoma

Sarcoma, Ewing, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡